Breakthrough stroke trial tests drug to boost recovery after emergency clot removal
NCT ID NCT07026318
Summary
This study is testing whether adding a medication called tirofiban after emergency clot removal (endovascular therapy) helps people recover better from a severe stroke. It will involve 716 patients who have had a stroke caused by a blocked brain artery. Half will receive tirofiban and half will receive a placebo (inactive substance) after their procedure, and researchers will compare how well they function 90 days later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital Affiliated to Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 101118, China
Conditions
Explore the condition pages connected to this study.